Annual report on Joint Drug Agreement issued

Major League Baseball conducted nearly 8,000 tests for performance-enhancing substances and/or stimulants in the last year, with 12 returning positive results that resulted in discipline, MLB and the MLB Players Association announced jointly on Monday.

There were two tests that revealed PEDS, one each for Boldenone and Methandienone. The other 10 were for stimulants (eight Adderall, one Methylhexaneamine and one Modafanil). In addition, there was one non-analytical positive test resulting in discipline.

The report from the Independent Program Administrator, Dr. Jeffrey M. Anderson, covers the period from the beginning of the 2013-14 offseason to the end of the 2014 World Series and includes players on 40-man rosters. The Joint Drug Prevention and Treatment Program calls for a public report to be issued by Dec. 1 of each year.

The total number of tests conducted was 7,929, including 6,394 urine samples and 1,535 blood samples that were collected and analyzed for the presence of Human Growth Hormone.

There were 113 Therapeutic Use Exemptions granted, one for hypogonadism and the remainder for Attention Deficit Disorder.

Paul Hagen is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.